Myocardial mhc isoform switching during diabetes is prevented by treatment with etomoxir, as well as a second fatty acid oxidation inhibitor, methylpalmoxirate (Dillmann, 1985; Rupp et al. 1994). This evidence concerns the gene HLA-C and diabetes mellitus.